Inflammation  >>  Monofer (iron isomaltoside 1000)  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Monofer (iron isomaltoside 1000) / Pharmacosmos
OVI-IBD, NCT05581420: Oral Versus Intravenous Iron in IBD Patients With Anti-inflammatory Therapy.

Recruiting
N/A
152
Europe
Ferrous fumarate, MonoFer, Ferinject, Cosmofer, Venofer
Leiden University Medical Center, University Medical Center Groningen, UMC Utrecht, Rijnstate Hospital, Erasmus Medical Center, Sint Franciscus Gasthuis, Adrz, Goes, Medical Center Haaglanden
Inflammatory Bowel Diseases
05/25
05/25
Comparative iron treatment for patients with IBD and IDA, ChiCTR2200066056: A comparative study of iron isomaltoside versus traditional iron supplements in patients with inflammatory bowel diseases and iron deficiency anemia

Not yet recruiting
N/A
200
 
iron isomaltoside; traditional iron supplements
Sir Run Run Shaw Hospital, Zhejiang University School of Medicine; Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Bethune Charitable Foundation
Inflammatory bowel disease
 
 
ChiCTR2200066959: Study on the effect of iron supplementation on the efficacy of anti-TNF-α monoclonal antibody in patients with IBD

Not yet recruiting
N/A
200
 
iron isomaltoside ;Without intervention
Sir Run Run Shaw Hospital, Zhejiang University School of Medicine; Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Bethune Charitable Foundation
Inflammatory bowel disease
 
 

Download Options